A clinical trial to compare two drugs, levetiracetam and valproate in children with seizure.
Phase 2
Completed
- Conditions
- Health Condition 1: G409- Epilepsy, unspecified
- Registration Number
- CTRI/2021/07/034552
- Lead Sponsor
- Pandit BDSharma UHSRPGIMS ROHTAK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children aged 3 years to 14 years with convulsive status epilepticus (clonic, tonic, tonic clonic, focal or generalised) who are neurologically normal prior to current illness will be enrolled.
Exclusion Criteria
Acute or chronic liver disease or kidney disease.
Children with global developmental delay or intellectual disability.
Severe protein energy malnutrition.
Patients who have received the study drug prior to presentation in emergency department
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to measure the proportion of patients in whom status epilepsy was aborted within twenty minutes after infusion started with no recurrence prior to sixty minutes after the start of infusion.Timepoint: 20 minutes <br/ ><br>60 minutes
- Secondary Outcome Measures
Name Time Method any acute adverse event following interventional drug administration.Timepoint: 1 day